Natural Biocon (India) Limited has intimated the stock exchanges about an upcoming Board of Directors meeting scheduled for Friday, August 14, 2026. The meeting will be held at the company's Registered Office.
The Board will consider and approve the following agenda items:
- Review and approval of the Unaudited Financial Results for the first quarter ended June 30, 2026, including the Auditor's Limited Review Report thereon
- Consideration and approval of the appointment of M/s Nirav S Shah & Co as the new Statutory Auditors of the Company
- Note the resignation of M/s Mayur Shah & Associates as the current Statutory Auditors of the Company
- Any other business with the permission of the Chairman
The disclosure is made pursuant to Regulation 29 read with other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is signed by Arunkumar Prajapati, Managing Director (DIN: 08281232), and addressed to both BSE Limited and The Calcutta Stock Exchange Ltd.